DealPulse Signal Wk 33: Rare Disease Took Two Thirds of the Week
Jazz paid $820 million for a Phase 1b asset. PTC paid $111 million for a filed one. The difference was not clinical risk, it was…
DealPulse Signal
The Beats
Analysis
The Briefs
Two TROP2 Conjugates Reached the Same Patients Ten Weeks Apart, and Payers Finally Have a Choice to Make
CMS Projects: Fewer Losses and Bigger Savings. That Only Works If the Sick Are Removed.
Two Dominican High-Cost Lists Overlap by Only 44 Products. FOMAC Would Be a Third.
The Effect Size Is 0.81. The Number That Decides the Business Is 6.4 Hours.
Lilly Can Sue the Sellers. It Can Only Ask the Payment Networks.
